Blog

Science

Predicting the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL) – The Princess Máxima Center for Pediatric Oncology

The Princess Máxima Center for Pediatric Oncology/LinkedIn

Dec 16, 2024, 13:20

Predicting the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL) – The Princess Máxima Center for Pediatric Oncology

The Princess Máxima Center for Pediatric Oncology posted on LinkedIn:

“Two new studies start thanks to funding from KWF Kankerbestrijding (Dutch Cancer Society) – Alpe d’HuZes. Ruben van Boxtel, Maarten Geurts and Friso Calkoen want to be able to predict the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL). And Jorik van Rijn aims to find leads for the development of CAR T cell therapy for children with T-lymphoblastic leukemia or lymphoma (T-LBLL).”

Predicting the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL) - The Princess Máxima Center for Pediatric Oncology

Alpe d'HuZes. Ruben van Boxtel cancer CAR T-cell therapy Dutch Cancer Society Friso Calkoen Jorik van Rijn KWF Dutch Cancer Society Maarten Geurts OncoDaily Oncology T-lymphoblastic leukemia The Princess Máxima Center Pediatric Oncology

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer